# The Human Medicines Regulations 2012, Paragraph 36: Suspensions of UK marketing authorisations that have effect immediately before IP completion day that were imposed under Chapter 4 of Title III of the 2001 Directive or Regulation (EC) No 726/2004


Where, immediately before IP completion day, a marketing authorisation, which is a UK marketing authorisation on IP completion day, has been suspended pursuant to the procedures in Chapter IV of Title III of 2001 Directive or Regulation (EC) No 726/2004, the suspension—
(a) continues to have effect on and after IP completion day in accordance with the terms on which it was imposed; and
(b) is to be treated as if it had been imposed by the licensing authority under Part 5 (marketing authorisations).

---
Source: https://www.legislation.gov.uk/uksi/2012/1916/schedule/33A/paragraph/36 (the official version)
Page: https://openlegislation.uk/human-medicines-regulations-2012/schedule-33A/paragraph-36
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.